Carisma Therapeutics INC. (CARM) SEC Filings — 2025
19 SEC filings for Carisma Therapeutics INC. (CARM) in 2025.
Filings
- Carisma Therapeutics INC. 8-K Filing — 8-K · Dec 5, 2025
- Carisma Swings to Profit Amid Wind-Down, Nasdaq Delisting — 10-Q · Nov 12, 2025
- Carisma Therapeutics Files 8-K on Officer/Director Changes — 8-K · Oct 15, 2025
- Carisma Therapeutics Faces Delisting Notice — 8-K · Oct 9, 2025
- Carisma Therapeutics Terminates Material Definitive Agreement — 8-K · Sep 18, 2025
- Carisma Therapeutics Reports Material Agreements & Control Changes — 8-K · Aug 29, 2025
- Carisma Therapeutics Files 8-K on Shareholder Vote Matters — 8-K · Aug 8, 2025
- Carisma Merges with OrthoCellix, Pivots to Gene Therapy — 10-Q · Aug 7, 2025
- Carisma Therapeutics Files Proxy Statement — DEFA14A · Jul 31, 2025
- Carisma Therapeutics Faces Delisting Concerns — 8-K · Jul 15, 2025
- Carisma Seeks Reverse Stock Split Approval to Boost Share Price — DEF 14A · Jul 7, 2025
- Carisma Therapeutics Inc. Files 8-K: Material Agreement — 8-K · Jun 23, 2025
- Carisma Therapeutics Files 8-K — 8-K · Jun 12, 2025
- Carisma Therapeutics Files Q1 2025 10-Q — 10-Q · May 13, 2025
- Carisma Therapeutics Files 2024 10-K Amendment — 10-K/A · Apr 29, 2025
- Carisma Therapeutics Faces Delisting Notice — 8-K · Apr 16, 2025
- Carisma Therapeutics Files 2024 10-K — 10-K · Mar 31, 2025
- Carisma Therapeutics Inc. Files 8-K, Details Name Changes — 8-K · Jan 13, 2025
- Carisma Therapeutics Faces Delisting Notice — 8-K · Jan 10, 2025